Cornea/External Disease News

For patients with progressive keratoconus, corneal cross-linking is indicated to slow or stop the progression of the disease.

The FDA has warned consumers not to purchase and to immediately stop using 26 over-the-counter eye drop products due to potential risk for eye infections.

NEW YORK — In this Healio Video Perspective from OSN New York, Jennifer Loh, MD, discusses why ophthalmologists must be aware of the crossover between thyroid eye disease and dry eye disease.

Well now, it seems as though I ruffled more than a few feathers with my annual anti-inflammatory review last month.

Aurion Biotech announced that the first participant has been dosed in its phase 1/2 trial of AURN001, an investigational cell therapy for treatment of corneal edema secondary to corneal endothelial dysfunction.

Have you ever seen Jeff Dunham, the ventriloquist, perform?

The FDA has granted clearance to the expansion of Heidelberg Engineering’s Anterion platform, according to a press release.

NEW YORK — In this Healio Video Perspective from OSN New York, Susan Benton, president of Thea Pharma, discusses Iyuzeh for primary open-angle glaucoma. The treatment launched during the meeting.

NEW YORK — In this Healio Video Perspective from OSN New York, Blake Williamson, MD, explains how to combine a small aperture IOL and the Light Adjustable Lens in post-refractive ectatic corneas.

NEW YORK — In this Healio Video Perspective from OSN New York, Parag A. Majmudar, MD, discusses the need for ophthalmologists to embrace a paradigm shift toward treating patients with keratoconus in the early stages of disease.